Cadmium effects on p38/MAPK isoforms in MDA-MB231 breast cancer cells

Caterina Casano1, Maria Agnello, Rosalia Sirchia

  • 1Dipartimento di Biologia Cellulare e dello Sviluppo, Università, Viale delle Scienze, 90128 Palermo, Italy.

Insights

The heavy metal cadmium (Cd) affects gene expression in breast cancer cells. This study reveals Cd exposure modulates p38 protein kinase isoforms, suggesting new regulatory mechanisms.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Toxicology

Background:

  • Cadmium (Cd) is a heavy metal known to affect gene expression and cellular signaling.
  • The p38 mitogen-activated protein kinase (MAPK) family, with isoforms alpha, beta, gamma, and delta, plays a crucial role in cell physiology and signal transduction.

Purpose of the Study:

  • To investigate the effects of cadmium exposure on p38 isoform expression, accumulation, and activation in MDA-MB231 human breast cancer cells.
  • To explore potential novel gene regulation mechanisms influenced by cadmium stress in mammary tumor cells.

Main Methods:

  • Treatment of MDA-MB231 cells with 5 microM cadmium chloride (CdCl2).
  • Utilized proliferation tests, conventional and semiquantitative multiplex (SM)-polymerase chain reaction (PCR), and Western blot assays.
  • Assessed the impact of SB203580 on p38 alpha and beta isoform activity.

Main Results:

  • Cadmium exposure induced diverse modulations in the transcription patterns of p38 isoform genes.
  • Accumulation of p38 protein isoforms was altered following cadmium treatment.
  • p38 alpha and beta isoform activity was affected by functional inactivation using SB203580.

Conclusions:

  • Cadmium exposure significantly impacts p38 signaling pathways in breast cancer cells.
  • The findings suggest previously unrecognized mechanisms of gene regulation by cadmium.
  • The MDA-MB231 cell line serves as a valuable in vitro model for studying stress-induced p38 regulation in mammary tumors.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...